Clinical Trials in Clayton, Melbourne
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Endometrioid Ovarian CancerFallopian Tube CancerEpithelial Ovarian Cancer+1 more
TORL Biotherapeutics, LLC230 enrolled66 locationsNCT06690775
Recruiting
Phase 2Phase 3
Preventing Systemic Inflammation After Cardiac Surgery With Alkaline Phosphatase
Systemic Inflammation
Alloksys Life Sciences B.V.1,250 enrolled21 locationsNCT03050476